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Abstract 
Infusion of inositol-3,4,5,6_tetrakisphosphate (Ins(3,4,5,6)P,) from the patch pipette into the cytoplasm, produced a biphaslc intracellular free Ca” 
concentration ([Ca”],) increase in ras-transformed NIW3T3 (DT) cells. The Ins(3,4,5,6)P,-induced increase in DT cells depended upon extracellular 
Ca2’, and was enhanced by membrane hyperpolanzation. Identical [Ca”], increases were observed with intracellular application of inositol-1,3,4,5- 
tetrakisphosphate (Ins(l,3,4S)P.,) and mositol-1,3,4,6_tetrakisphosphate bu  not with inositol-1,2,4,5-tetrakisphosphate, mositol-1,4,5-trisphosphate 
or inositol-1,3,4,5.6-pentakisphosphate. Stimulation of DT cells with bradykinin increased the levels of Ins(3,4,5,6)P, and Ins(l,3,4,5)P,. These results 
suggest hat Ins(3,4,5,6)P, may serve as a second messenger for contmuous Ca *+ influx along with other tetrakisphosphates downstream from 
bradykinin receptors in DT cells. 
Key words: Receptor operated Ca ‘+ influx; Intracellular Ca*’ concentration; I ositol polyphosphate; Second messenger; Mouse 
fibroblast 
1. Instruction 
Inositol tetrakisphosphates are formed after stimula- 
tion of receptors for hormones and neurotransmitters in 
mammalian cells. Inositol-1,3,4,5_tetrakisphosphate 
(Ins( 1,3,4,5)P,) is produced by phosphorylation of inos- 
itol-1,4,5_trisphosphate (Ins( 1,4,5)P,) after application 
of agonist [1,2]. Ins(1,3,4,5)P, serves as a source inositol 
phosphate for producing inositol-1,3,4,5,6_pentakis- 
phosphate (Ins( 1,3,4,5,6)PJ via inositol-1,3,4-trisphos- 
phate [3,4]. Recently it has been shown that agonists can 
increase the level of inositol-3,4,5,6_tetrakisphos- 
phate (Ins(3,4,5,6)P,) [5-91, from which one pathway of 
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formation is dephosphorylation of Ins(1,3,4,5,6)P, from 
the abundant precursor pool of the cell membrane [9, lo]. 
However, the functional role of Ins(3,4,5,6)P, is not 
known [lo]. 
Here we report the effect of intracellular application 
of Ins(3,4,5,6)P, on intracellular free Ca” concentration 
([Ca”],) in fura- loaded mouse fibroblasts under volt- 
age- clamp conditions. To characterize the mechanism of 
the Ca’+ influx produced by Ins(3,4,5,6)P, in mouse fi- 
broblasts, we used Ki-ras-transformed NIH/3T3 fibro- 
blast cells, in which we have demonstrated Cal+ influx 
induced by Ins(1,3,4,5)P, [ll]. Furthermore, we meas- 
ured the Ins(3,4,5,6)P, as well as Ins( 1,3,4,5)P, levels in 
ras-transformed fibroblasts stimulated with bradykinin 
in order to address the question of whether inositol 
tetrakisphosphates can be second messengers for 
bradykinin- induced Ca” influx in the cells. 
2. Materials and methods 
2 1 Cell culture 
tz-Ki-ras-transformed NIH/3T3 fibroblasts (DT cells) [I 1] were 
grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% fetal calf serum. Cells were plated at a density of 1-l .5 x 10’ 
cells/mm’ on a fluorescence-free glass coverslip attached to a silicone 
tube (1.5-cm diameter and 0.9-cm height) with silicone sealant and 
cultured for 2 days at 37°C. 
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2.2. [Ca”], measurement 
Microspectrofluorometric determination of [Ca”], with fura- was 
performed in DT cells, as described previously [I 1,121. Briefly, they 
were loaded with 5 PM fura- acetoxymethylester (Dojindo Laborato- 
ries, Kumamoto, Japan) for 45 min at 37’C. Fluorescence was meas- 
ured at 35°C at a determined site through a pin hole (l&20 pm) with 
alternating excitation wavelengths of 340 and 380 nm, using a Ca” 
microspectrometric system (model OSP-3, Olympus Opical Co., 
Tokyo). 
2.3. Patch clamp and intracellular application 
Patch voltage-clamp on fura-2-loaded cells was performed in the 
whole-cell configuration with a patch electrode [13], as described previ- 
ously [l 11. DT cells were superfused at 35°C with Docherty’s Cal’ 
solution 1141 of the following composition (in mM), slightly modified 
from the ogginal recipe: CaCI,, 2; ietraethyiammo&mchl&de, 100; 
CsCl, 5; MgCl,, 1; glucose, 25; HEPES, 25, pH 7.3 (buffered by about 
7.5 mM CsOH). Ca2+-free solution was prepared by omitting CaCl, and 
adding 0.1 mM EGTA to the solution. Patch electrodes contained 
solution of the following composition (in mM): CsCl, 150; MgCl,, 1; 
&a*ATP, 1; fura-2, 0.1; HEPES, 10, pH 7.2, buffered with CsOH. The 
resistance of electrodes filled with the solution was 8-16 MS1. About 
90 s after the initial touch, the electrode tip was sealed to the cell body 
by suction (seal resistance, >l GQ), and the membrane patch under the 
electrode tip was broken by further suction. After successfully establish- 
ing the whole-cell recording mode the cell was voltage-clamped. 
Inositol polyphosphates (10 PM) dissolved in intracellular ecording 
medium in the patch pipettes were applied by diffusion into the cyto- 
plasm after rupture of the membrane patch to establish whole-cell 
mode. 
2 4. Inositol tetrakisphosphate measurement 
Cells were cultured in inositol-free DMEM supplemented with 10% 
fetal calf serum. They were labeled with [‘flinositol (7.7 &i/ml, 
myo[3H]inositol, 19.8 GBq/ mg (535 mCi/mg), Amersham, UK) for 96 
h. All experiments were carried out at 37°C. At the end of the labeling 
protocols, the culture medium was aspirated, and cells were incubated 
for 20 min in HEPES- DMEM (pH 7.4). [3H]inositol phosphate forma- 
tlon was initiated by replacing the preincubation buffer with fresh 
HEPES-DMEM containing 1 ,uM bradykinin, and incubation was con- 
tmued for O-10 min. The reaction was stopped by adding to each well 
50 ~1 of ice-cold 100% trichloroacetic acid (final concentration 4.8%). 
After centrifugation, the supematant was neutralized by adding 1 N 
NaOH. and treated with water-saturated diethylether (3 ml x 3). The 
[‘Hlinositol tetrakisphosphates in the samples- were separated on a 
Pertisphere Wax column (Whatman, Maidstone, UK), according to the 
method of Wong et al. [15]. 
2.5. Drugs 
Ins(1.4,5)P, and inositol-3-monophosphate (Iris(3)),) were pur- 
chased from Doiindo Laboratories. Ins(3,4.5.6)P, 1161, Ins(1,3,4,5)P, 
[17] and inositol-i,3,4,6_tetrakisphophate(Ins(i ,j,@i)@4) [18jwere syn- 
thesized according the methods described by Watanabe t al. Inositol- 
1,2,4,5_tetrakisphosphate (Ins( 1,2,4,5)P,) was synthesized by the 
method described elsewhere by one of the authors (M.H.). 
3. Results and discussion 
Application of 10 ,uM Ins(3,4,5,6)P, through a patch 
pipette in ras-transformed NIH/3T3 (DT) cells held at 
-40 mV resulted in an initial elevation of [Ca*+]], fol- 
lowed by a sustained increase, in the presence of ex- 
tracellular Ca” (n = 7) (Fig. lA-a and B and Table l), 
with the ED,, of about 8 ,uM. Elevation of [Ca”], was 
completely abolished in zero extracellular Ca*+ ([Ca”],) 
in = 8) (Fig. lA-b), and the elevation was recovered by 
restoration of external Ca*+. On the contrary, the [Ca*‘]i 
rise evoked by injection of Ins(1,4,5)P, into the cyto- 
plasm of DT cells was transient and was observed even 
in the absence of extracellular Ca*’ (Fig. 1B and Table 
1). The results show that the source of Ca*+ for the 
Ins(3,4,5,6)P,-induced [Ca*‘], increase is extracellular in 
both the initial and sustained phases and for Ins( 1,4,5)P, 
is largely due to mobilization of Ca*’ from intracellular 
stores [2] in DT cells. 
As shown in Fig. 2A, Ins(3,4,5,6)P,-evoked [Ca”], in- 
creased as the membrane potential was hyperpolarized 
in DT cells. [Ca”], in both the initial and late phases 
following injection of Ins(3,4,5,6)P, increased signifi- 
cantly as the membrane potential hyperpolarized below 
- 15 or -40 mV, respectively (Fig. 2B), probably because 
of increased electrochemical driving forces [l 11. Mem- 
brane hyperpolarization itself caused little or no increase 
of [Ca”li as shown in inositol phosphate-free cells (Fig. 
2C). A similar hyperpolarization-enhanced Ca*’ influx 
has been reported in oocytes expressing muscarinic sub- 
type m3 receptors [19]. 
The specificity of the action of Ins(3,4,5,6)P, on Ca*+ 
influx was examined by applying other inositol tetrakis- 
phosphate isomers in DT cells (Table 1). Ins(1,3,4,5)P, 
and Ins(1,3,4,6)P, (10 PM in pipettes) produced similar 
biphasic [Ca*‘], elevations in the presence of external 
Ca*+, as for Ins(3,4,5,6)P,, and complete suppression was 
observed in the absence of external Ca*‘. Interestingly, 
Ins( 1,2,4,5)P,, a nonbiological synthetic inositol tetra- 
kisphosphate, resulted in transient but extracellular 
Ca*‘-dependent Ca*+ influx, as produced by the three 
naturally occurring inositol tetrakisphosphates. 
Ins( 1 ,3,4,5,6)P5, Ins(3)P, and GDP-/?-S had no ability for 
Ca*’ mobilization and Ca” influx. GTP-y-S reproduced 
Table 1 
Effect of 10 PM inositol phosphates, 100 PM GTP-y-S and 100 PM 
GDP-B-S on [Ca2’], elevation in DT cells 
Compounds DT cells 
included in 
pipettes 2 mM [Ca”], 0 mM [Ca2’10 
Initial peak at 10 min at 1 min 
None 
Ins(3)P, 
Ins( 1,4,5)P, 
Ins(1,3,4,5)P, 
Ins(1,3,4,6)P, 
Ins(3,4,5,6)P, 
(3,4,5,6)P, + 
(1,4,5)P, 
Ins( 1,2,4,5)P, 
Ins(1.3,4.5,6)P, 
GTP-y-S 
GDP-B-S 
115+ 3(7) 
136 f 11 (6) 
211 f 15 (6)** 
430 f 70 (6)** 
441 f 72 (8)** 
334 f 29 (S)** 
387 + 40 (7)** 
208 + 23 (7)** 
123 + 16 (4) 
261 f. 40 (6)* 
117f 6(6) 
116f S(7) 
117f 5 (5) 
113f 8 (6) 
188 f 22 (6)* 
182 f 17 (5)* 
171 f 14 (7)* 
199 + 23 (7)* 
92 f 6 (4) 
100 f 4 (4) 
114f 4(4) 
122 * 13 (S) 
102 f 3 (5) 
105 f 1 (5) 
222 f 15 (5)** 
103 f 1 (5) 
100 f 0 (5) 
103 f 1 (8) 
241 f 41 (5)* 
107 f 4 (8) 
103 f 4 (6) 
215 +_ 27 (7)** 
103 f 1 (5) 
Data are shown as mean f S.E.M. of the [Ca”], level, represented as 
the percentage of the value of [Ca”], just before membrane breaking. 
Number of experiments are shown in parentheses. * and **, signifi- 
cantly different from values in isomer-free DT cells, P < 0.05 and 0.01, 
respectively. 
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Fig. 1. Effect of extracellular Ca*’ on the [Ca”], elevation induced by intracellular application of Ins(3,4,5,6)P, or Ins( 1,4,5)P, in DT cells. (A) [Ca”], 
was measured in DT cells in the presence of 2 mM extracellular Ca” (a) or in zero extracellular Ca2’ with 0.1 mM EGTA (b). Changes in [Ca”], 
were recorded under voltage-clamp with patch pipettes filled with 10 ,uM Ins(3,4,5,6)P,. Ins(3,4,5,6)P, was loaded into cells by diffusion from the 
pipettes after breaking the membrane at the time indicated by arrows. In (b), [Ca”], concentration was raised to 2 mM from about 4 min after injection, 
indicated by thick bars. The holding membrane potential was -40 mV. (B) Plots of time course of [Ca”], change produced by intracellular application 
of Ins(3,4,5,6)P, or Ins(1,4,5)P, in DT cells. [Ca”], levels are represented as% of the value of [Ca*‘], just before membrane rapture. Points show mean 
values in response to 10 PM Ins(3,4,5,6)P, (0, I)), 10 .uM Ins(l,4,5)P, (A, A), and Isomer-free control solution (m. q ), in the presence (filled symbols) 
or absence (open symbols) of 2 mM extracellular Ca2’, respectively. Bars Indicate S. E. M. Numbers of experiments are 5-7. * and **, significantly 
different from the values at the same time point in isomer-free cells, P < 0.05 and 0.01. respectively. 
the effect of Ins(1,4,5)P,, not that of the inositol tetra- 
kisphosphate. Use of Ins(3,4,5,6)P, in combination with 
Ins(1,4,5)P, had little or no additive effect, suggesting 
that Ca2’ influx is strictly specific to Ins(3,4,5,6)P, in DT 
cells. 
DT cells [I 11 or Xenopus oocytes with m3-muscarinic 
acetylcholine receptors expressed [19] possess a Calf in- 
flux pathway that becomes prominent by membrane hy- 
perpolarization. Interestingly, application of bradykinin 
to the ras-transformed cells [l l] or of acetylcholine to the 
oocytes [19] evokes repetitive transient increases of Ca’+, 
or cytosolic Ca2+ oscillations. Ca”+ oscillations in these 
preparations have been reported to occur in an extracel- 
lular Ca2’ dependent-manner and to be enhanced by 
hyperpolarization [11,191. This suggests that Ca” influx 
across the plasma membrane is necessary for mainte- 
nance of agonist-induced Ca’+ oscillations. Therefore, 
we measured the Ins(3,4,5,6)P, and Ins(l,3,4,5)P, levels 
in ras-transformed fibroblasts stimulated with bradyki- 
nin. 
The pre-stimulating control level of Ins( 1 ,3,4,5)P4 and 
Ins(3,4,5,6)P, was 768 + 18 dpm (mean & S.E.M., n = 4) 
and 131 ? 24 dpm (n = 4) in DT cells, respectively. 
Bradykinin stimulation increased the level of radioac- 
tivity in 13H]Ins( 1,3,4,5)P, by 2.6- to 3.1-fold and 
[3H]Ins(3,4,5,6)P, by 2.8- to 5.0-fold (Fig. 3). 
r3H]Ins(l ,3,4,5)P, levels increased rapidly, while 
[3H]Ins(3,4,5,6)P, levels increased slowly, appearing to 
reach a plateau after 5 min following receptor activation. 
The maximal peak level was 2359 & 616 dpm (n = 3) at 
1 min for [3H]Ins(1,3,4,5)P, and 658 5 180 dpm (n = 3) 
at 5 min for [3H]Ins(3,4,5,6)P,, respectively. A similar 
long-lasting increase of the Ins(3,4,5,6)P, level has been 
reported in response to stimulation by angiotensin II in 
adrenal glomerulosa cells [5], fMLP in HL-60 myeloid 
cells [6], bombesin in AR&2J pancreatoma cells [7], and 
M. Hashii et al. IFEBS Letters 340 (1994) 276-280 219 
600 -: J 50 
-15 ww-l 100 
t 
50 
+35 e 
100 
4 ,7 50 
l . 
0 io i5 SO 
I 
O -90 
I I I I 1 I I I I I I 
-65 -40 -15 +lO +35 -90 -65 -40 -15 +lO +35 
Membrane potential (mv) 
Fig. 2. Relationship between [Ca*‘], and membrane potential in DT cells with or without Ins(3,4,5,6)P, injected. (A) Time course of [Ca”], in 
voltage-clamped DT cells at three different holding potentials. The membrane potential is shown at the left. 10 PM Ins(3,4,5,6)P, was infused into 
the cells at the time indicated by the arrow, as described in Fig. 1. Plots of [Ca”], as a function of membrane potential in the presence (B) or absence 
(C) of 10 PM Ins(3,4,5,6)P, in the pipettes. [Ca”], level is represented as % of the value of [Ca2’], just before membrane rupture. Each point shows 
the mean, and bars indicate S.E.M. Numbers of experiments are 5-8. Symbols indicate [Ca*‘], immediately after injection (0) and after 10 min (0). 
* and **, significantly different from values at the identical membrane potential in isomer-free DT cells as indicated in C, P < 0.05 and 0.01, 
respectively. 
vasopressin in WRK-1 rat mammary tumor cells [8]. 
Together, these results show that Ins(3,4,5,6)P, is a sec- 
ond messenger in a variety of cells but not specifically in 
ras-transformed cells. 
In the present experiment, intracellular injection of the 
three inositol tetrakisphosphates, Ins(3,4,5,6)P,, 
Ins( 1,3,4,5)P,, Ins(l,3,4,6)P,, mimicked the bradykinin- 
induced increases of [Ca”], due to Ca” influx in ras- 
transformed fibroblasts, with little or no specificity be- 
tween the three, but with a clear different action from 
those of Ins(1,4,5)P,, Ins(1,2,4,5)P,, and Ins(1,3,4,5,6)P,. 
In DT cells, Ins( 1,3,4,5)P, [l l] and Ins(3,4,5,6)P, do not 
require the simultaneous injection with Ins(1,4,5)P, in 
order to stimulate Ca*’ entry, as was reported previously 
[20], suggesting that these compounds alone can elicit 
Ca2’ influx. Recently, it has been shown that there are 
receptors for Ins(1,3,4,5)P, which are Ca2’-permeable 
channels in the plasma membrane [20-221. Our results 
suggest hat inositol tetrakisphosphate receptors and/or 
Ca*‘-permeable channels may have a non-selective sensi- 
tivity for the naturally occurring tetrakisphosphates 
tested. 
AS shown in Fig. lA, the [Ca2’]i increase evoked by 
Ins(3,4,5,6)P, in pipettes both in the presence of external 
Ca2’ and after Ca2’ restoration decayed to result in the 
biphases. Since fresh Ins(3,4,5,6)P, can be supplied 
through the pipettes, this decay may not be due to deg- 
radation of Ins(3,4,5,6)P,, but to negative feedback or 
desensitization of Ins(3,4,5,6)P, receptors to inactivate 
Ca*+ influx. 
Three pathways which lead to accumulation of 
Ins(3,4,5,6)P, are known: (i) dephosphorylation by l- 
phosphatase action on Ins(1,3,4,5,6)P, [5,7,9]; (ii) inhi- 
bition of Ins(3,4,5,6)P,-l-kinase [lo]; or (iii) isomerase 
action on inositol- 1,4,5,6_tetrakisphosphate [9]. Which- 
ever route is taken transformed NIH/3T3 cells, the level 
of Ins(3,4,5,6)P, was slowly increased in response to 
bradykinin. Although Ins(1,3,4,5)P, formation was 
much larger than that of Ins(3,4,5,6)P, in ras-trans- 
formed cells, the findings suggest hat Ins(3,4,5,6)P, is a 
second messenger downstream from bradykinin receptor 
stimulation, specially in the late phase. 
As a preliminary result, we have observed that appli- 
cation of Ins(3,4,5,6)P, into parental ‘untransformed’ 
NIH/3T3 fibroblast cells produces an initial elevation of 
[Ca*‘], but no sustained elevation. The difference in re- 
sponse between control and ras-transformed cells seems 
not to lie in a quantitative difference in Ins(3,4,5,6)P, 
formation but in a mechanism whereby Ins(3,4,5,6)P,- 
induced Ca*+ influx is maintained at a higher level in 
rus-transformed cells. The important question arises as 
to why Ins(3,4,5,6)P, injection produces only a Ca2’ pla- 
teau rather than mimics cytosolic Ca*+ oscillations in rus- 
transformed cells. The reason may reside on no activa- 
tion of Ca*’ pumps which may not be induced by injec- 
tion of Ins(3,4,5,6)P,, whereas application of bradykinin 
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Fig. 3. Changes in the level of [3H]-labelled Ins(1,3,4,5)P, and 
Ins(3,4,5,6)P, in DT cells m response to bradykinin. Cells were labelled 
to equilibrium with [‘HI mositol and then stimulated with 1 ,uM 
bradykinin for the periods indicated. Inositol tetrakisphosphates were 
extracted and separated by high pressure liquid chromatography on 
Partisphere-WAX columns and their radioactivities were determined. 
Each point shows the mean of levels of [‘H]Ins(1,3,4,5)P, (m) and 
[3H]Ins(3,4,5,6)P., (0)at the indicated time points. Bars indicate S.E.M. 
Numbers of experiments are 336. 
may be able to do, as pointed out previously [ll]. In 
summary, Ins(3,4,5,6)P, in concert with other tetra- 
kisphosphates may play an important role in producing 
Ca” influx to maintain the [Ca”], at a certain level dur- 
ing cytosolic Ca2+ oscillations following agonist-stimula- 
tion in ras-transformed fibroblast cells. 
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